PAREXEL International Corporation Company Profile (NASDAQ:PRXL)

About PAREXEL International Corporation (NASDAQ:PRXL)

PAREXEL International Corporation logoPAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:PRXL
  • CUSIP: 69946210
  • Web: www.parexel.com
Capitalization:
  • Market Cap: $4.5 billion
  • Outstanding Shares: 51,115,000
Average Prices:
  • 50 Day Moving Avg: $87.85
  • 200 Day Moving Avg: $79.27
  • 52 Week Range: $51.16 - $88.10
P/E:
  • Trailing P/E Ratio: 42.76
  • Foreward P/E Ratio: 19.53
  • P/E Growth: 1.50
Sales & Book Value:
  • Annual Revenue: $2.12 billion
  • Price / Sales: 2.12
  • Book Value: $12.42 per share
  • Price / Book: 7.09
Profitability:
  • EBITDA: $340.1 million
  • Net Margins: 4.49%
  • Return on Equity: 28.98%
  • Return on Assets: 7.94%
Debt:
  • Debt-to-Equity Ratio: 1.01%
  • Current Ratio: 1.45%
  • Quick Ratio: 1.45%
Misc:
  • Average Volume: 839,481 shs.
  • Beta: 0.77
  • Short Ratio: 0.57
 

Frequently Asked Questions for PAREXEL International Corporation (NASDAQ:PRXL)

What is PAREXEL International Corporation's stock symbol?

PAREXEL International Corporation trades on the NASDAQ under the ticker symbol "PRXL."

How were PAREXEL International Corporation's earnings last quarter?

PAREXEL International Corporation (NASDAQ:PRXL) posted its earnings results on Monday, August, 28th. The company reported $1.02 EPS for the quarter, topping analysts' consensus estimates of $0.94 by $0.08. The business had revenue of $557.20 million for the quarter, compared to analysts' expectations of $537.59 million. PAREXEL International Corporation had a net margin of 4.49% and a return on equity of 28.98%. During the same period in the previous year, the company posted $0.94 earnings per share. View PAREXEL International Corporation's Earnings History.

When will PAREXEL International Corporation make its next earnings announcement?

PAREXEL International Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for PAREXEL International Corporation.

Where is PAREXEL International Corporation's stock going? Where will PAREXEL International Corporation's stock price be in 2017?

12 brokerages have issued 12-month price objectives for PAREXEL International Corporation's shares. Their predictions range from $53.00 to $88.10. On average, they expect PAREXEL International Corporation's stock price to reach $73.71 in the next twelve months. View Analyst Ratings for PAREXEL International Corporation.

Who are some of PAREXEL International Corporation's key competitors?

Who are PAREXEL International Corporation's key executives?

PAREXEL International Corporation's management team includes the folowing people:

  • Josef H. von Rickenbach, Chairman of the Board, Chief Executive Officer
  • Mark A. Goldberg M.D., President, Chief Operating Officer
  • Simon Harford, Chief Financial Officer, Senior Vice President
  • Xavier AB Flinois, President - PAREXEL Informatics
  • Michelle Graham, Chief Human Resource Officer, Senior Vice President
  • Sybrand Pretorius M.D., Senior Vice President, Chief Scientific Officer
  • Douglas Alexander Batt, Senior Vice President, General Counsel, Secretary
  • Roland Andersson Ph.d., Senior Vice President - Clinical Research Services
  • Christian Dreger Ph.D., Senior Vice President - Parexel Access and Parexel Consulting
  • David J. Godwin, Senior Vice President-Global Business

Who owns PAREXEL International Corporation stock?

PAREXEL International Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Longfellow Investment Management Co. LLC (0.14%). Company insiders that own PAREXEL International Corporation stock include A Dana Callow Jr, Eduard E Holdener, Gadi Saarony, Joshua Schultz, Patrick J Fortune, Richard L Love, Sybrand Pretorius and Ulf I Schneider. View Institutional Ownership Trends for PAREXEL International Corporation.

Who bought PAREXEL International Corporation stock? Who is buying PAREXEL International Corporation stock?

PAREXEL International Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Longfellow Investment Management Co. LLC. View Insider Buying and Selling for PAREXEL International Corporation.

How do I buy PAREXEL International Corporation stock?

Shares of PAREXEL International Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PAREXEL International Corporation's stock price today?

One share of PAREXEL International Corporation stock can currently be purchased for approximately $88.08.


MarketBeat Community Rating for PAREXEL International Corporation (NASDAQ PRXL)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  259 (Vote Outperform)
Underperform Votes:  381 (Vote Underperform)
Total Votes:  640
MarketBeat's community ratings are surveys of what our community members think about PAREXEL International Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for PAREXEL International Corporation (NASDAQ:PRXL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $73.71 (16.31% downside)
Consensus Price Target History for PAREXEL International Corporation (NASDAQ:PRXL)
Price Target History for PAREXEL International Corporation (NASDAQ:PRXL)
Analysts' Ratings History for PAREXEL International Corporation (NASDAQ:PRXL)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/21/2017Jefferies Group LLCReiterated RatingHold$88.10LowView Rating Details
6/20/2017Barclays PLCDowngradeOverweighr -> Equal Weight$87.00HighView Rating Details
6/20/2017Raymond James Financial, Inc.UpgradeUnderperform -> Mkt PerformHighView Rating Details
6/6/2017Credit Suisse GroupReiterated RatingNeutral$65.00 -> $83.00LowView Rating Details
5/30/2017MizuhoBoost Price TargetBuy -> Buy$66.00 -> $75.00LowView Rating Details
5/23/2017Goldman Sachs Group IncUpgradeSell -> Neutral$63.00 -> $77.00LowView Rating Details
5/15/2017Evercore ISIUpgradeIn-Line -> Outperform$85.00LowView Rating Details
2/3/2017Deutsche Bank AGDowngradeHold -> Sell$66.00 -> $53.00N/AView Rating Details
2/3/2017Citigroup Inc.DowngradeBuy -> NeutralN/AView Rating Details
11/23/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
11/17/2016First AnalysisDowngradeOverweight -> Equal Weight$62.00N/AView Rating Details
11/11/2016SunTrust Banks, Inc.DowngradeBuy -> Hold$80.00 -> $60.00N/AView Rating Details
10/27/2016Robert W. BairdDowngradeOutperform -> Neutral$78.00 -> $67.00N/AView Rating Details
7/18/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
5/22/2016KeyCorpReiterated RatingHoldN/AView Rating Details
4/11/2016Avondale PartnersLower Price TargetUnderperform$50.50 -> $49.00N/AView Rating Details
(Data available from 10/21/2015 forward)

Earnings

Earnings History for PAREXEL International Corporation (NASDAQ:PRXL)
Earnings by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)
Earnings History by Quarter for PAREXEL International Corporation (NASDAQ PRXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$0.87N/AView Earnings Details
8/28/2017Q4 2017$0.94$1.02$537.59 million$557.20 millionViewN/AView Earnings Details
5/3/2017Q3 2017$0.73$0.74$529.38 million$529.30 millionViewListenView Earnings Details
10/26/2016Q117$0.86$0.76$525.15 million$500.90 millionViewListenView Earnings Details
8/3/2016Q416$0.93$0.94$532.41 million$538.60 millionViewListenView Earnings Details
4/27/2016Q316$0.90$0.89$523.16 million$527.10 millionViewListenView Earnings Details
1/27/2016Q2$0.72$0.90$523.03 million$518.50 millionViewListenView Earnings Details
10/28/2015Q116$0.63$0.70$511.77 million$512.10 millionViewListenView Earnings Details
8/5/2015Q415$0.74$0.79$527.13 million$523.00 millionViewListenView Earnings Details
4/29/2015Q315$0.66$0.66$513.50 million$502.03 millionViewListenView Earnings Details
1/28/2015Q215$0.60$0.69$502.20 million$499.27 millionViewListenView Earnings Details
10/30/2014Q115$0.58$0.65$505.60 million$491.69 millionViewListenView Earnings Details
8/7/2014Q414$0.62$0.65$508.99 million$510.60 millionViewListenView Earnings Details
4/29/2014Q314$0.54$0.56$493.35 million$492.40 millionViewListenView Earnings Details
1/30/2014Q214$0.49$0.49$479.49 million$487.10 millionViewListenView Earnings Details
10/30/2013Q114$0.45$0.45$458.94 million$449.20 millionViewListenView Earnings Details
8/7/2013Q4 2013$0.43$0.50$455.23 million$463.10 millionViewListenView Earnings Details
4/30/2013Q3 2013$0.40$0.50$438.10 million$454.49 millionViewListenView Earnings Details
1/29/2013Q2 2013$0.33$0.41$419.78 million$422.10 millionViewListenView Earnings Details
10/30/2012Q113$0.29$0.29$396.70 million$394.80 millionViewN/AView Earnings Details
4/30/2012$0.31$0.33ViewN/AView Earnings Details
1/30/2012$0.23$0.23ViewN/AView Earnings Details
10/31/2011$0.15$0.20ViewN/AView Earnings Details
8/9/2011$0.07$0.10ViewN/AView Earnings Details
5/2/2011$0.30$0.27ViewN/AView Earnings Details
1/31/2011$0.28$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PAREXEL International Corporation (NASDAQ:PRXL)
2017 EPS Consensus Estimate: $3.73
2018 EPS Consensus Estimate: $3.86
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$0.85$0.87$0.87
Q2 20175$0.82$0.99$0.89
Q3 20175$0.71$1.08$0.99
Q4 20175$0.91$1.16$0.98
Q1 20185$0.85$0.94$0.88
Q2 20185$0.93$0.99$0.96
Q3 20185$0.94$0.98$0.97
Q4 20184$1.04$1.10$1.06
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PAREXEL International Corporation (NASDAQ:PRXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for PAREXEL International Corporation (NASDAQ:PRXL)
Insider Ownership Percentage: 2.90%
Institutional Ownership Percentage: 87.45%
Insider Trades by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)
Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)
Insider Trades by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/3/2017Sybrand PretoriusSVPSell8,050$65.12$524,216.00View SEC Filing  
2/9/2017Gadi SaaronyInsiderSell2,325$64.54$150,055.50View SEC Filing  
8/15/2016Gadi SaaronyInsiderSell2,500$70.05$175,125.00View SEC Filing  
8/9/2016Joshua SchultzSVPSell2,500$68.64$171,600.00View SEC Filing  
6/13/2016A Dana Callow JrDirectorSell3,000$60.04$180,120.00View SEC Filing  
6/2/2016Eduard E HoldenerDirectorSell700$62.98$44,086.00View SEC Filing  
5/25/2016Ulf I SchneiderSVPSell7,500$62.00$465,000.00View SEC Filing  
5/24/2016Ulf I SchneiderSVPSell6,000$61.00$366,000.00View SEC Filing  
5/23/2016Ulf I SchneiderSVPSell6,000$60.01$360,060.00View SEC Filing  
5/20/2016Ulf I SchneiderSVPSell8,000$59.24$473,920.00View SEC Filing  
3/30/2016Richard L LoveDirectorSell1,330$62.50$83,125.00View SEC Filing  
12/1/2015Richard L LoveDirectorSell1,330$68.21$90,719.30View SEC Filing  
11/24/2015Eduard E HoldenerDirectorSell2,200$67.66$148,852.00View SEC Filing  
11/12/2015Gadi SaaronySVPSell12,425$67.01$832,599.25View SEC Filing  
11/11/2015Patrick J FortuneDirectorSell1,500$68.07$102,105.00View SEC Filing  
9/1/2015Richard L LoveDirectorSell1,330$64.26$85,465.80View SEC Filing  
8/18/2015Mark A GoldbergCOOSell8,995$73.49$661,042.55View SEC Filing  
8/18/2015Thomas SenderovitzSVPSell1,500$74.02$111,030.00View SEC Filing  
6/18/2015Mark A GoldbergCOOSell11,507$70.03$805,835.21View SEC Filing  
5/14/2015Richard L LoveDirectorSell5,000$65.00$325,000.00View SEC Filing  
3/19/2015Mark A GoldbergCOOSell12,884$68.99$888,867.16View SEC Filing  
3/2/2015A Dana Callow JrDirectorSell2,000$65.84$131,680.00View SEC Filing  
2/19/2015Christopher J LindopDirectorSell2,000$63.59$127,180.00View SEC Filing  
2/13/2015Rickenbach Josef H VonCEOSell65,100$62.53$4,070,703.00View SEC Filing  
2/6/2015Eduard E HoldenerDirectorSell3,000$62.97$188,910.00View SEC Filing  
2/4/2015Douglas A BattSVPSell8,300$60.89$505,387.00View SEC Filing  
2/3/2015Gadi SaaronyVPSell8,525$60.97$519,769.25View SEC Filing  
12/3/2014Mark A GoldbergCOOSell25,345$58.99$1,495,101.55View SEC Filing  
11/5/2014Christopher J LindopDirectorSell12,000$55.00$660,000.00View SEC Filing  
8/20/2014Gadi SaaronyVPSell6,075$57.78$351,013.50View SEC Filing  
8/18/2014Anita CooperVPSell4,916$57.56$282,964.96View SEC Filing  
8/15/2014Anita CooperVPSell5,084$57.50$292,330.00View SEC Filing  
8/14/2014Anita CooperVPSell6,800$57.54$391,272.00View SEC Filing  
8/13/2014Mark A GoldbergCOOSell16,761$56.33$944,147.13View SEC Filing  
8/11/2014Richard L LoveDirectorSell6,000$57.33$343,980.00View SEC Filing  
6/5/2014Patrick J FortuneDirectorSell3,000$53.04$159,120.00View SEC Filing  
2/20/2014Anita CooperVPSell2,500$53.00$132,500.00View SEC Filing  
2/18/2014Mark GoldbergCOOSell11,206$52.49$588,202.94View SEC Filing  
2/12/2014Mark GoldbergCOOSell12,199$50.49$615,927.51View SEC Filing  
2/11/2014Anita CooperVPSell10,000$50.00$500,000.00View SEC Filing  
2/10/2014Eduard HoldenerDirectorSell6,000$49.62$297,720.00View SEC Filing  
2/10/2014Rickenbach Josef VonCEOSell50,000$49.76$2,488,000.00View SEC Filing  
2/7/2014Gadi SaaronyVPSell9,950$49.56$493,122.00View SEC Filing  
2/7/2014Rickenbach Josef VonCEOSell50,000$49.70$2,485,000.00View SEC Filing  
2/4/2014Christopher LindopDirectorSell10,000$49.00$490,000.00View SEC Filing  
2/3/2014Douglas BattSVPSell8,000$48.58$388,640.00View SEC Filing  
2/3/2014Mark GoldbergCOOSell13,529$48.70$658,862.30View SEC Filing  
1/13/2014Mark GoldbergCOOSell6,957$48.90$340,197.30View SEC Filing  
1/9/2014Mark GoldbergCOOSell6,901$46.49$320,827.49View SEC Filing  
12/12/2013Xavier FlinoisInsiderBuy5,000$41.11$205,550.00View SEC Filing  
9/11/2013Patrick FortuneDirectorSell7,000$48.31$338,170.00View SEC Filing  
8/28/2013Richard LoveDirectorSell5,000$47.04$235,200.00View SEC Filing  
6/4/2013Douglas A BattSVPSell15,000$45.15$677,250.00View SEC Filing  
6/3/2013Mark A GoldbergCOOSell15,000$45.06$675,900.00View SEC Filing  
5/20/2013Richard L LoveDirectorSell8,000$46.65$373,200.00View SEC Filing  
5/14/2013A Dana Callow JrDirectorSell8,000$46.39$371,120.00View SEC Filing  
5/13/2013Mark A GoldbergCOOSell28,887$45.19$1,305,403.53View SEC Filing  
5/10/2013Anita CooperVPSell10,000$44.99$449,900.00View SEC Filing  
5/9/2013Ulf I SchneiderSVPSell20,510$44.54$913,515.40View SEC Filing  
10/4/2012Mark A GoldbergCOOSell5,000$32.00$160,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for PAREXEL International Corporation (NASDAQ:PRXL)
Latest Headlines for PAREXEL International Corporation (NASDAQ:PRXL)
Source:
DateHeadline
americanbankingnews.com logoAnalyzing PAREXEL International Corporation (PRXL) and Its Rivals
www.americanbankingnews.com - October 17 at 12:54 PM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) to Release Earnings on Tuesday
www.americanbankingnews.com - October 17 at 6:26 AM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 8 at 2:44 PM
marketwatch.com logoPamplona Capital Management Completes Acquisition of PAREXEL International
www.marketwatch.com - September 29 at 6:18 PM
finance.yahoo.com logoSix Flags Entertainment and Sterling Bancorp Set to Join S&P MidCap 400; Oil States Intl. and KEMET to Join S&P SmallCap 600
finance.yahoo.com - September 26 at 7:05 PM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) & Exact Sciences Corporation (EXAS) Financial Comparison
www.americanbankingnews.com - September 24 at 12:20 AM
finance.yahoo.com logoPAREXEL International Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management
finance.yahoo.com - September 19 at 6:44 AM
americanbankingnews.com logo$538.12 Million in Sales Expected for PAREXEL International Corporation (PRXL) This Quarter
www.americanbankingnews.com - September 14 at 10:05 AM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - September 13 at 4:46 PM
finance.yahoo.com logoETFs with exposure to PAREXEL International Corp. : September 7, 2017
finance.yahoo.com - September 8 at 7:17 AM
finance.yahoo.com logoPAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
finance.yahoo.com - September 7 at 7:52 AM
finance.yahoo.com logoPAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
finance.yahoo.com - September 7 at 7:52 AM
finance.yahoo.com logoPAREXEL International Corp. :PRXL-US: Earnings Analysis: 2017 By the Numbers : September 1, 2017
finance.yahoo.com - September 2 at 7:43 AM
americanbankingnews.com logoBrokers Issue Forecasts for PAREXEL International Corporation's Q1 2018 Earnings (PRXL)
www.americanbankingnews.com - August 31 at 10:39 AM
nasdaq.com logoAfter-Hours Earnings Report for August 28, 2017 : PRXL, CTLT, PSEC, AMSWA, EXA, PRCP - Nasdaq
www.nasdaq.com - August 29 at 6:54 AM
finance.yahoo.com logoParexel beats Street 4Q forecasts - Yahoo Finance - Yahoo Finance
finance.yahoo.com - August 29 at 6:54 AM
finance.yahoo.com logoParexel beats Street 4Q forecasts
finance.yahoo.com - August 29 at 6:54 AM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) Posts Earnings Results, Beats Expectations By $0.09 EPS
www.americanbankingnews.com - August 28 at 8:22 PM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) Short Interest Update
www.americanbankingnews.com - August 28 at 1:48 AM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) Expected to Announce Quarterly Sales of $537.57 Million
www.americanbankingnews.com - August 26 at 11:52 AM
americanbankingnews.com logo Analysts Anticipate PAREXEL International Corporation (PRXL) to Post $0.94 EPS
www.americanbankingnews.com - August 24 at 2:10 PM
finance.yahoo.com logoPAREXEL Ties Up With Osaka International Cancer Institute
finance.yahoo.com - August 22 at 4:02 PM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - August 22 at 10:30 AM
finance.yahoo.com logoPAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
finance.yahoo.com - August 22 at 6:03 AM
finance.yahoo.com logoPAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
finance.yahoo.com - August 22 at 6:03 AM
globenewswire.com logoSHAREHOLDER ALERT: Rigrodsky & Long, PA Files Class Action Suit Against PAREXEL International Corporation - GlobeNewswire (press release)
globenewswire.com - August 17 at 3:22 PM
prnewswire.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PAREXEL International ... - PR Newswire (press release)
www.prnewswire.com - August 17 at 3:22 PM
feeds.benzinga.com logoSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against PAREXEL International Corporation
feeds.benzinga.com - August 15 at 9:28 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PAREXEL International Corporation - PRXL
finance.yahoo.com - August 15 at 6:25 AM
americanbankingnews.com logoNovavax (NVAX) & PAREXEL International Corporation (PRXL) Financial Analysis
www.americanbankingnews.com - August 14 at 8:42 AM
americanbankingnews.com logoShort Interest in PAREXEL International Corporation (NASDAQ:PRXL) Declines By 30.5%
www.americanbankingnews.com - August 14 at 2:14 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about PAREXEL International Corp.
finance.yahoo.com - August 13 at 4:07 AM
finance.yahoo.com logoIHS Markit Score Update: Drop in demand for ETFs holding PAREXEL International Corp is a negative sign for its shares
finance.yahoo.com - August 11 at 7:45 AM
finance.yahoo.com logoPAREXEL International Corporation -- Moody's assigns a B2 CFR to PAREXEL; outlook stable
finance.yahoo.com - August 9 at 6:34 AM
finance.yahoo.com logoPAREXEL International Corporation Announces $720 Million Senior Notes Offering by West Street Merger Sub, Inc.
finance.yahoo.com - August 8 at 6:21 AM
finance.yahoo.com logoTwo PAREXEL Executives Named to 2017 PharmaVOICE 100
finance.yahoo.com - August 2 at 6:50 AM
americanbankingnews.com logoPAREXEL International Corporation (PRXL) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - July 25 at 4:51 PM
prnewswire.com logoStock Performance Review on Medical Labs & Research Industry -- PAREXEL, China Cord Blood, ICON, and PRA ... - PR Newswire (press release)
www.prnewswire.com - July 20 at 6:26 AM
americanbankingnews.com logoShort Interest in PAREXEL International Corporation (PRXL) Drops By 58.3%
www.americanbankingnews.com - July 16 at 7:22 AM
seekingalpha.com logoPAREXEL International Corporation (PRXL)
seekingalpha.com - July 12 at 7:08 AM
finance.yahoo.com logoPAREXEL Receives CEO Cancer Gold Standard Re-Accreditation
finance.yahoo.com - July 12 at 7:08 AM
businesswire.com logoPAREXEL Named to the Forbes America's Best Employers List for ... - Business Wire (press release)
www.businesswire.com - June 27 at 7:33 AM
marketbeat.com logoPamplona Capital to take Parexel private in $5B cash deal
marketbeat.com - June 20 at 8:12 AM
seekingalpha.com logoUpside Potential From Possible Transaction At PAREXEL International
seekingalpha.com - May 26 at 6:10 AM
wsj.com logoActivist Investor Starboard Takes 5.7% Stake in Parexel International, Sources Say
www.wsj.com - May 17 at 12:04 AM
investorplace.com logoPAREXEL International Corporation (PRXL) and Pandora Media Inc (P) Lead 12 Activist Investor Reports
investorplace.com - May 12 at 1:36 PM
reuters.com logoStarboard buys 5.7 percent stake in Parexel, joining other activists
www.reuters.com - May 11 at 7:48 PM
marketbeat.com logoParexel beats 3Q profit forecasts
marketbeat.com - May 3 at 5:03 PM
bizjournals.com logoTriangle CROs among best to work with, says survey
www.bizjournals.com - April 3 at 6:47 PM
nasdaq.com logoPAREXEL International is Now Oversold (PRXL) - Nasdaq.com - Nasdaq
www.nasdaq.com - March 19 at 9:20 AM

Social

Chart

PAREXEL International Corporation (PRXL) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.